Zofenopril plus hydrochlorothiazide combination in the treatment of hypertension: an update.

Item

http://www.wikidata.org/entity/Q38237435

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Zofenopril plus hydrochlorothi ...... nt of hypertension: an update.

@en

type

Item

label

Zofenopril plus hydrochlorothi ...... nt of hypertension: an update.

@en

prefLabel

Zofenopril plus hydrochlorothi ...... nt of hypertension: an update.

@en

P1476

Zofenopril plus hydrochlorothi ...... ent of hypertension: an update

@en

P2093

Claudio Borghi

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

A systematic review of the associations between dose regimens and medication compliance.

Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

P304

1055-1065

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.2014.946405

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Omboni

P577

2014-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264563263

http://www.w3.org/2001/XMLSchema#string

P698

25098297

http://www.w3.org/2001/XMLSchema#string